Cleanfarms Running 2019 Collection Program In Manitoba

Oct 22, 2019

This week in Manitoba, Cleanfarms is running its 2019 collection program for unwanted pesticides and obsolete livestock/equine medications.

In most cases, collection days are scheduled at local agricultural retailers' sites and events are open from 9 a.m. to 4 p.m.

Materials accepted in the Cleanfarms program include:

- old or unwanted agricultural pesticides (identified with a Pest Control Product number on the label)

- commercial pesticides for golf courses and industrial and commercial pest control products (identified with a Pest Control Product number on the label)

- livestock/equine medications that are used in rearing animals in an agricultural context (identified with a DIN number, serial number or Pest Control Product number on the label)

The program will NOT accept:

- fertilizer, diluted solution, large quantities of unopened product, and treated seed

- needles/sharps, medicated feed, aerosol containers, premises disinfectants/sanitizers, veterinary clinic waste and medications, ear tags, and aerosols

- any other household hazardous waste.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.